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1. Introduction 
During the last years several examples have been 
presented showing how the covalent attachment of an 
enzyme inhibitor, cofactor, or substrate, to an inert 
matrix can provide an adsorbent useful for the selec- 
tive purification of an enzyme from a complex mix- 
ture [l-7] . The enzyme carbonic anhydrase is strong- 
ly and specifically inhibited by aromatic and hetero- 
cyclic sulfonamides [8,9]. These inhibitors would be 
expected to be useful in designing biospecific adsorb- 
ents for the enzyme. 
The present paper describes the chromatography 
of human and bacterial carbonic anhydrases on an 
adsorbent consisting of Sephadex or Sepharose to 
which sulfanilamide had been coupled. After adsorp- 
tion of the enzyme to the column elution can be 
brought about in a predictable manner by agents that 
are known to act competitively with sulfonamides. 
The human erythrocyte enzyme, as described else- 
where [9] , consists of a mixture of two forms that 
differ from each other in the structure of the bind- 
ing site for inhibitors. This difference can be utilized 
to separate the two isoenzymes by selective displace- 
ment after adsorption on a chromatography column. 
Preliminary results of this investigation have been 
communicated elsewhere [4] and later Whitney re- 
ported similar experiments [lo] . 
North-Holland Publishing Company - Amsterdam 
2. Materials and methods 
Sulfanilamide was coupled to Sephadex G- 150 and 
Sepharoses 2B, 4B, and 6B using the cyanogen bromide 
method described previously [I] . The degree of modi- 
fication of the polymers was determined by sulfur 
analysis [ 1 l] . Using a reaction mixture of 2 g of sul- 
fanilamide and 25 g (dry weight) of cyanogenbromide- 
activated Sephadex G-150 resulted in a product con- 
taining 13 mg (=75 pequiv.) of sulfonamide/g of dry 
polymer which corresponds to a yield in the coupling 
of 16%. Similarly, the modification of Sepharose 2B 
carried out with 2 g of sulfanilamide per 5 g of polymer 
gave 48 mg (= 280 pequiv.) of sulfonamide/g of dry 
polymer corresponding to a yield of 12%. 
Forms B and C of the human erythrocyte carbonic 
anhydrase were purified as described elsewhere [ 121 
but avoiding lyophilization for enzyme C. Bacterial 
carbonic anhydrase was derived from Neisseria sicca, 
strain 602 1, as described by Adler et al. [ 131. 
Carbonic anhydrase activity was assayed as the 
esterase reaction following the hydrolysis of p-nitro- 
phenyl acetate [ 141 or by measuring the rate of the 
carbon dioxide hydration by the method of Wilbur 
and Anderson [ 151 as modified by Rickli et al. [ 161 
A histidine side chain in the active-site region of 
human carbonic anhydrase B was chemically modified 
by the specific reaction with bromoacetate described 
by Whitney et al. [ 141. The reaction was stopped 
half-way, i.e. at a residual activity of 5.5%, by putting 
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the reaction mixture on a column containing Sephadex 
G-25. The product derived which contained 0.5 1 equiv- 
alents of carboxymethylhistidine was fractionated on 
sulfanilamide-Sephadex as described in the caption to 
fig. 2. 
Column chromatographies were carried out under 
experimental conditions described in the captions to 
the figures. Flow-rates were usually kept constant by 
using a peristaltic pump and fractions were collected 
with a time-regulated fraction collector. Protein con- 
centrations were determined spectrophotometrically 
at 280 nm or by the ninhydrin reaction using a cali- 
bration curve constructed from a standard solution of 
the carbonic anhydrase to be analyzed. 
3. Results and discussion 
Fig. 1 shows how human carbonic anhydrase B 
can be adsorbed to the sulfanilamide-Sephadex and 
displaced from the column by acetazolamide. Aceta- 
zolamide is a potent carbonic anhydrase inhibitor of 
the sulfonamide type [8] with a dissociation con- 
stant (I$) for the enzyme-inhibitor complex of about 
5 X lop7 M at the pH of the experiment. Acetazol- 
amide acts competitively with the sulfanilamide 
groups covalently fixed to the adsorbent and the en- 
zyme is eluted from the column as an enzyme-aceta- 
zolamide complex. In fig. 1 as in subsequent figures 
a minor amount of protein runs unadsorbed through 
1.01 M Tris- 
sulfate, Gradient to 10s4 M acetazolamide 
#H 8.0 , in 0.01 M Tris-sulfate, pH 8.0 
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Fig. 1. Chromatography of human carbonic anhydrase B on sulfanilamide-Sephadex. 8.5 mg of enzyme in 0.01 M Tris-sulfate, 
pH 8.0, was applied to the column. The enzyme was displaced by the addition of an enzyme inhibitor of the sulfonamide type, 
acetazolamide, which was applied in the form of a linear gradient as indicated by the dotted line. Column dimensions: 120 X 10 
mm. Temperature: 8810”. Fraction volume: 2-3 ml. Flow rate: about 30 mI/hr. Due to the absorption in ultraviolet displayed 
by acetazolamide, the protein determination was carried out by the ninhydrin reaction. The material in the first peak did contain 
no or only trace amounts of enzyme activity. 
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Fig. 2. Separation by affinity chromatography of native human carbonic anhydrase B from enzyme chemically modified in the 
active site region. The enzyme was modified by the specific reaction with bromoacetate described by Whitney et al [ 141, which 
leads to the carboxymethylation of a histidine side chain in the active-site region. The reaction was interrupted halfway giving a 
product containing 0.5 1 equivalents of carboxymethylhistidine. This product, dissolved in 4 ml of 0.1 M Tris-sulfate, pH 8.0, 
was applied to a column with sulfanilamide-Sephadex quilibrated with the same buffer. Elution was carried out as indicated in 
the figure. Column dimensions: 110 X 12 mm. Temperature: 8-10’. Fraction volume: about 2 ml. Flow rate: 15 ml/hr. Frac- 
tions containing protein were pooled and lyophilized. The fist peak gave about 5.4 mg and contained 0.72 equivalents of car- 
boxymethylhistidines while the second peak consisting of about 4.5 mg of protein contained only trace amounts (- 0.03 equiv.) 
of modified histidine. 
the column. This material has been ascribed to im- 
purities in the enzyme preparation used in the experi- 
ments or, more likely, to carbonic anhydrase mole- 
cules having the inhibitor-binding site destroyed by 
denaturation. 
The specificity in the interaction of carbonic an- 
hydrase with the sulfanilamide-Sephadex is further 
illustrated by the experiment shown in fig. 2. Here a 
preparation of human carbonic anhydrase B partially 
altered in its active site by chemical modification has 
been chromatographed. Treatment of the human B 
enzyme with bromoacetate [ 141 or iodoacetate [ 171 
leads to the insertion of a carboxymethyl group into 
the active site region. This group which becomes 
covalently attached to a histidine side chain is known 
to interfere with the binding of sulfonamides increas- 
ing their KI values everal orders of magnitude [ 181. 
Fig. 2 illustrates how a preparation of human carbonic 
anhydrase B, carboxymethylated to about 50%, is 
separated on the sulfanilamide-Sephadex intotwo 
fractions differing in the content of modified histi- 
dine. The material retained on the column and sub- 
sequently eluted with 0.5 M NaI represents unmodi- 
fied enzyme while the fraction running through the 
column has a content of carboxymethylhistidine 
higher than the material applied to the column. 
The experiment in fig. 2 resembles that reported 
by Whitney [lo] who purified human carbonic an- 
hydrase B chemically modified in its active site with 
iodoacetamide [ 181. The modified enzyme was pre- 
pared from the reaction mixture by passing through 
a column packed with Sepharose to which p-amino- 
methylbenzenesulfonamide hadbeen coupled. 
X-ray diffraction studies on human carbonic an- 
hydrase C [ 191 show that the active site of the en- 
zyme where the sulfonamide inhibitors bind, is 
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located in a crevice in the protein molecule. The zinc 
ion to which has been ascribed a central role in the 
catalytic reaction is located at the bottom of the 
cavity [9]. Sulfonamide inhibitors bind with their 
sulfonamide group oriented towards the metal ion. 
Monovalent anions like halide ions also inhibit the 
enzyme. They compete with the sulfonamide inhibi- 
tors as judged from investigations of the enzyme in 
solution [20]. X-ray diffraction studies on enzyme- 
inhibitor complexes also show that halide ions and 
sulfonamides have overlapping binding sites [2 I] . 
Halide ions would therefore be expected to displace 
carbonic anhydrase from the specific adsorbent. This 
prediction is validated by the results in fig. 3. Cyanate 
is another inhibitor competing with sulfonamide bind- 
ing [22]. It binds several orders of magnitude more 
strongly to the enzyme than the halide ions. The use 
of cyanate as eluting agent is also demonstrated in 
fig. 3. 
Human carbonic anhydrases B and C differ in the 
structure of their active site as is evident from dissimi- 
larities in catalytic properties [23] and binding of sul- 
fonamide inhibitors [24] . At pH around 8 the KI 
values for sulfanilamide can be estimated to about 
20 X 10P6 and 5 X 10e6 M, respectively, i.e. the in- 
hibitor associates more weakly with enzyme B than 
with the C form. The halide ions, on the other hand, 
show stronger affinity to enzyme B than to the C 
form [9]. The differences between the two forms of 
the human carbonic anhydrase in inhibitor binding is 
reflected in the behaviour of the proteins on sulfanil- 
amide-Sephadex (fig. 3 B and C). It can be utilized 
for separating the two proteins from each other in a 
single run as demonstrated in fig. 3D. 
For both human carbonic anhydrases the binding 
strength of halide ions increases in the order 
Cl- < Br- <I- [9]. Fig. 3 B shows how human car- 
bonic anhydrase B after adsorption to the column 
can be eluted by 0.1 M NaI. If NaCl is used instead 
Fig. 3. Chromatography of human carbonic anhydrases B 
(HCA B) and C (HCA C) on suli?anilamideBephadex. Serum 
albumin was also chromatographed on the same column as 
an example of a protein without specific interaction with 
the adsorbent. Column dimensions: 90 X 12 mm. Tempera- 
ture: 8-10”. Fraction volume: 2 ml. Flow rate (kept con- 
stant with a peristaltic pump): 6.8 ml/hr. S-10 mg of pro- 
tein was applied to the column. Stepwise elution was carried 
out as specified in the diagrams. 
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the concentration required for displacing the protein 
from the column should be higher. Successful elu- 
tions have been carried out with 2 M NaCl. The bind- 
ing of halide ions increases with decreasing pH while 
the strength of sulfonamide binding in the same pH 
range becomes weaker [9] . This phenomenon would 
imply that in chromatography of carbonic anhydrase 
on sulfonamide-containing specific adsorbents the 
control of pH would be of importance for reproduci- 
bility. Alternatively, controlled changes pf pH could 
be utilized for the purpose of separation. Fig. 3 C and 
D show how NaI at pH 7.5 is a suitable eluting agent 
for enzyme B while the C enzyme remains attached 
to the column. By lowering the pH, NaI can also be 
used to displace the C enzyme from the adsorbent as 
demonstrated in fig. 3 E. 
The utilization of the specific adsorbent for pre- 
parative purposes is illustrated in figs. 4 and 5. Fig. 4 
shows the purification of a bacterial carbonic anhy 
drase from Neisseria sicca. This enzyme resembles 
human carbonic anhydrase C in sulfonamide inhibi- 
tion [25] and fig. 4 shows how the bacterial protein 
can be purified from a crude extract by adsorption 
and subsequent elution from the column under con- 
ditions similar to those found useful in the case of 
the human enzymes given in fig. 3. Fig. 5 illustrates 
the purification of the two human forms from hemol- 
ysate of red blood cells using the same experimental 
conditions as used in the chromatography of the 
purified enzyme forms (fig. 3). Another example re- 
ported elsewhere [26] is the purification of a carbonic 
anhydrase from human kidney that appears to be in- 
distinguishable from the C form isolated from erythro- 
cytes. 
The behaviour of carbonic anhydrases on sulfanil- 
amide-Sephadex described above can clearly be ac- 
counted for in terms of active-site-specific binding as 
determining adsorption and desorption of the enzyme. 
The experimental conditions utilize only part of the 
vast knowledge about inhibitor binding to carbonic 
anhydrase [8,9]. Several other possibilities remain 
to be exploited, in particular there would be a great 
choice of sulfonamide inhibitors for producing ad- 
sorbents [8]. In addition to the investigations with 
sulfanilamide-Sephadex described above, a few ex- 
periments were also carried out with sulfanilamide 
cuopled to Sepharose. The results obtained were less 
reproducible than for the Sephadex derivative. As 
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Fig. 4. Purification of bacterial carbonic anhydrase from 
Neisseria sicca on sulfanilamide-Sephadex. A crude extract 
of enzyme from step 2 in the procedure of Adler et al. [ 131 
was dialyzed against 0.1 M Tris-sulfate, pH 7.5, and applied 
to the column, preequilibrated with the same buffer. The 
column was washed with buffer and the enzyme eluted with 
0.1 M T&sulfate, pH 7.5 + 0.01 M KCNO. Enzyme activity 
( - - - - -) and protein concentration (-_) were 
determined as described in Materials and methods. Column 
dimensions: 100 X 12 mm. Room temperature. Fraction 
volume: 3 ml. Flow rate: 18 ml/hr. 
will be reported elsewhere (Sundberg arrd W%Istrand) 
technical improvements can be made by coupling 
sulfanilamide to a spacer incorporated on cross-linked 
agarose [27]. 
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Fig. 5. Chromatography of hemolysate on sulfanilamideBephadex. Human erythrocytes were washed with 0.9% NaCl and hemol- 
yzed with distilled water. The hemolysate was very carefully dialyzed against 0.1 M Tris-sulfate, pH 7.5, and centrifuged. 25 ml 
were applied to the column. Washing with buffer brought the hemoglobin through the column together with a certain amount of 
enzymic activity. Carbonic anhydrases B (HCA B) and C (HCA C) were subsequently eluted with 0.1 M NaI and 0.01 M KCNO in 
T&sulfate, pH 7.5 as in the chromatograms shown in fig. 3. Enzymic activity (- - - - - - - -) and protein concentration (------ ) 
were determined as described in Materials and methods. Column dimensions: 150 X 20 mm. Room temperature. Fract. vol. 4-5 ml 
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